Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00162357 · ClinicalTrials.gov registry record · Phase 4

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

A Phase 4 study, sponsored by Lantheus Medical Imaging.

Completed
Registry status
Phase 4
Development phase
106
Enrollment target

NCT00162357: Completed Phase 4 study, sponsored by Lantheus Medical Imaging.

NCT00162357 is a Phase 4 study that has completed, run by Lantheus Medical Imaging. The registered enrollment target is 106 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00162357, a Phase 4 study, has completed, sponsored by Lantheus Medical Imaging.

COMPLETED
Registry status
Phase 4
Development phase
106 participants
Enrollment target

Study Summary

The purpose of this clinical research study is determine if patients with diabetes that have undergone previous opening of a heart blockage may have a blockage that is not causing any symptoms that may be detected by imaging with Cardiolite.

Interventions

  • DRUG Technetium Tc99m Sestamibi

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2004-04
Est. Completion 2005-12
Phase Phase 4
Lantheus Medical Imaging

22 total trials

What the finished NCT00162357 record still lists

NCT00162357 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 1 intervention - of which Technetium Tc99m Sestamibi is the first listed.

NCT00162357 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00162357 about?

NCT00162357 is a clinical study titled "Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty". The purpose of this clinical research study is determine if patients with diabetes that have undergone previous opening of a heart blockage may have a blockage that is not causing any symptoms that may be detected by imaging with Cardiolite.

What is the current status of trial NCT00162357?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 106 participants. The study started on 2004-04. Estimated completion is 2005-12.

What interventions are being tested in trial NCT00162357?

The interventions under investigation include: Technetium Tc99m Sestamibi (DRUG).

Who is sponsoring clinical trial NCT00162357?

This trial is sponsored by Lantheus Medical Imaging, which has 22 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00162357's enrollment target sits among peer trials

106 747th of 2000 higher than 1,252 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00162357, the US trial registry maintained by the National Library of Medicine. NCT00162357 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.